# A Prospective Clinical Audit to Improve Compliance With Perioperative Atrial Fibrillation Prevention Protocols in Off-Pump Coronary Artery Bypass Surgery

**Authors:** Md. Ziaur Rahman, Mushfiqun Islam, Md. Sajidujjaman, Snahashish Chakroborty, SM Rashidul Hasan

PMC · DOI: 10.7759/cureus.103090 · Cureus · 2026-02-06

## TL;DR

This study shows that implementing structured quality-improvement measures in heart surgery significantly reduces new-onset atrial fibrillation by improving protocol compliance.

## Contribution

The study demonstrates that targeted interventions can halve postoperative atrial fibrillation in off-pump coronary surgery patients.

## Key findings

- Continuation of beta-blocker on the morning of surgery improved from 66.3% to 94.1%.
- Serum potassium maintenance within target increased from 42.1% to 81.2%.
- New-onset AF incidence decreased from 34.7% to 16.8% after interventions.

## Abstract

Background

New-onset atrial fibrillation (AF) is a frequent complication following cardiac surgery and is associated with significant mortality and morbidity. This audit evaluated adherence to perioperative AF prevention standards and the effect of targeted quality-improvement measures in off-pump coronary artery bypass grafting (OPCAB) patients.

Methodology

Two prospective audit cycles were performed at the Apollo Imperial Hospitals. Cycle 1 (January to September 2024; n=95 eligible) established baseline compliance with three standards: the continuation of beta-blocker on the morning of surgery, maintenance of perioperative serum potassium at 4.5-5.0 mmol/L, and reinstitution of beta-blocker within 12 hours postoperatively. After multidisciplinary interventions (permanent ICU/OR posters, checklist attached to patient records, weekly team meetings, and four-times-daily ward rounds), improvement was assessed in cycle 2 (November 2024 to July 2025; n=101). Bisoprolol was the institutional beta-blocker; ivabradine was used if beta-blockers were contraindicated. Categorical variables were analyzed using the chi-square test or Fisher’s exact test, and relative risk (RR) and odds ratios (OR) were estimated with 95% confidence intervals (CI).

Results

Preoperative beta-blocker continuation improved from 66.3% to 94.1% (p<0.001). Serum potassium maintenance within target increased from 42.1% to 81.2% (p<0.001). Reinstitution rates were high in both cycles (96.8% versus 95.0%, p=0.72). New-onset AF incidence decreased from 34.7% to 16.8% (p=0.0067; RR: 0.48 {95% CI: 0.29-0.81}; OR: 0.38 {95% CI: 0.19-0.74}).

Conclusion

Structured, multidisciplinary quality-improvement measures significantly improved compliance with AF prevention protocols and were associated with a decrease in postoperative AF incidence by 50% in OPCAB patients. Routine audits and sustained adherence to protocol are recommended.

## Linked entities

- **Chemicals:** bisoprolol (PubChem CID 2405), ivabradine (PubChem CID 132999)
- **Diseases:** atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Diseases:** COPD (MESH:D029424), heart block (MESH:D006327), stroke (MESH:D020521), left ventricular dysfunction (MESH:D018487), arrhythmia (MESH:D001145), myocardial ischemia (MESH:D017202), AF (MESH:D001281), Hypokalemia (MESH:D007008), congestive heart failure (MESH:D006333)
- **Chemicals:** ivabradine (MESH:D000077550), K+ (MESH:D011188), beta-blockade (-), Bisoprolol (MESH:D017298)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967809/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967809/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967809/full.md

---
Source: https://tomesphere.com/paper/PMC12967809